PFE Stock Price - Pfizer Inc - (PFE)
- Prev. Close: 34.16
- Open: 34.44
- Daily Range: 34.23 - 34.60
PFE NEWS FROM BIDNESS ETC
Pfizer Inc, Eli Lilly, AstraZeneca plc and Bristol-Myers Squibb See Increas...
According to sell-side analysis report, cancer drugs sales of pharmaceutical giants have significantly increased in February
Pfizer Inc, Eli Lilly To Recommence Phase 3 Trials For Pain Drug Tanezumab
FDA’s final decision to remove the partial hold on Pfizer and Lilly’s lead pain drug candidate will prove to open doors for a high value adding op...
Pfizer Inc. (PFE) StockTo Appreciate Significantly, Says Jefferies
Jefferies has lifted the target price on Pfizer stock from $42 to $45 on “multiple deep dives, which show multiple ways to win”
- Pfizer Inc. Publishes Prevenar 13 Data From CAPiTA Study
- Dementia Drug Research Aided By $100 Million Venture Capital Funding
- Insider Selling: Pfizer Inc. (PFE), FireEye Inc (FEYE), CBS Corporation (CB...
- Pfizer Inc. Plans To Expand Its Vaccine Portfolio; Strategic Acquisitions M...
- Drug-Makers Endorse “Cap The Copay” As A New Pressure Tactic Against In...
- FDA Keeps Serious Warning On Pfizer Inc. Anti-Smoking Drug, Chantix
- Pfizer Inc. Wins European Commission Approval For New Prevenar 13 Indicatio...
- JP Morgan Raises EPS Estimates For Pfizer (PFE) Stock
- Pfizer, Inc., Novartis AG Criticize CDC’s Recommendation For Meningitis B...
More News From Bidness
NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corpora... PUBLISHED: Feb 25, 2015 at 6:20 am ESTInsider Selling: General Motors Company (GM), Pfizer In... PUBLISHED: Feb 17, 2015 at 9:05 am ESTHospira, Inc. Profits Exceed Estimates On Strong Sales ... PUBLISHED: Feb 13, 2015 at 3:45 pm ESTPfizer Inc. (PFE) Strikes A $5 Billion Accelerated Shar... PUBLISHED: Feb 10, 2015 at 6:23 am EST
Hospira, Inc. Acquisition Calls For A Price Target Raise On Pfizer (PFE) Stock: Citi PUBLISHED: Feb 9, 2015 at 1:33 pm EST
Here’s Why BMO Capital Markets Sees Upside In Pfizer Inc. Stock PUBLISHED: Feb 9, 2015 at 1:33 pm EST
BMO Capital Markets analyst Alex Arfaei weighed in on Pfizer following the announcement of Hospira acquisitionREAD MORE
Pfizer Inc. GEP Unit To Become Largest Biosimilar And Generic Drugs Developer PUBLISHED: Feb 9, 2015 at 8:56 am EST
Pfizer is expected to become the leader in the biosimilar and generic drugs market, following its $17 billion acquisition of HospiraREAD MORE
Pfizer Inc. Is Not Done With Acquisition Deals Yet PUBLISHED: Feb 9, 2015 at 7:04 am EST
Pfizer recently acquired Hospira in a $17 million deal and further plans to buy out more companies to boost its pipeline and shareholder valueREAD MORE
Hospira, Inc. Stock Jumps After Pfizer Inc. (PFE) Agrees To Acquisition PUBLISHED: Feb 5, 2015 at 2:58 pm EST
Hospira shares jumped to an all-time high as Pfizer announced it would acquire the company in a $17 billion dealREAD MORE
Pfizer Inc. To Acquire Hospira (HSP) For $17 Billion PUBLISHED: Feb 5, 2015 at 9:07 am EST
Pfizer will acquire Hospira for $17 billion, in hopes to strengthen the former’s biosimilar pipeline, by the second half of 2015READ MORE